Synapse

← Surgical Oncology Insight

Papers in Surgical Oncology Insight

Page 2 · newest first

  1. Society of surgical oncology medical student & trainee primer for hepatopancreatobiliary surgical oncologySurgical Oncology Insight · 2025
  2. Society of surgical oncology medical student & trainee primer for skin, soft tissue, and endocrine surgical oncologySurgical Oncology Insight · 2025
  3. National trends in emergency and non-emergency colorectal cancer resections across the COVID-19 pandemicSurgical Oncology Insight · 2025
  4. The tumour microenvironment score outperforms established molecular classifiers as a prognostic factor for disease-free interval and disease-specific survival in non-metastatic gastric cancerSurgical Oncology Insight · 2025
  5. Intraoperative carcinoid crisis in NET operations – Eluding Dogma with current understandingSurgical Oncology Insight · 2025
  6. Neoadjuvant chemotherapy in patients ≥70 with node-positive triple negative breast cancerSurgical Oncology Insight · 2025
  7. Comparative survival analysis of gallbladder neuroendocrine carcinoma and adenocarcinoma following radical surgery: A secondary analysis of the multicenter Algerian GBC group studySurgical Oncology Insight · 2025
  8. Taiwan expert consensus on the clinical integration of antibody-drug conjugates in advanced breast cancerSurgical Oncology Insight · 2025
  9. HOXA13 overexpression is associated with poor prognosis in colorectal liver metastasesSurgical Oncology Insight · 2025
  10. The use of neoadjuvant immunotherapy may be associated with increased surgical complications In women with triple-negative breast cancerSurgical Oncology Insight · 2025
  11. Age and muscle measures predict benefit of surgery in locally-advanced adenocarcinoma of the esophagusSurgical Oncology Insight · 2025
  12. Supporting the PACT Act: Top cancers diagnosed in young veterans who deployed to Iraq and AfghanistanSurgical Oncology Insight · 2025
  13. Dissecting the PRADO (Personalized Response-driven ADjuvant cOmbination therapy) trial in melanoma for surgical oncologists; safety and feasibility of surgical de-escalation after neo-adjuvant immunotherapy for macroscopic stage III melanomaSurgical Oncology Insight · 2025
  14. A single arm, prospective, open label, multicenter study assessing the safety and effectiveness of SPY AGENT GREEN and SPY fluorescence imaging systems in the visualization of lymphatic vessels and lymph nodes during lymphatic mapping and sentinel lymph node biopsy in subjects with breast cancerSurgical Oncology Insight · 2025
  15. Littoral cell angioma unveiled: Exploring diagnosis, treatment, and malignant potentialSurgical Oncology Insight · 2025
  16. Current status of intraoperative radiation therapy in rectal cancer: A national cancer database analysisSurgical Oncology Insight · 2025
  17. Assessing the ability of Timed Up and Go and Modified Frailty Index-5 compared to Fried frailty index to objectively identify frail patients undergoing evaluation for surgerySurgical Oncology Insight · 2025
  18. Taiwan Expert Consensus on the appropriate treatment strategies for HER2-low breast cancerSurgical Oncology Insight · 2025
  19. Maximum stomach area on preoperative CT predicts delayed gastric emptying in palliative gastrojejunostomySurgical Oncology Insight · 2025
  20. Body composition and post-operative outcomes after minimally-invasive esophagectomySurgical Oncology Insight · 2025
  21. Pre-operative biomarkers may predict nodal status in pancreatic ductal adenocarcinomaSurgical Oncology Insight · 2025
  22. Characterization of ultrarare sarcomas in a high-volume referral center in Latin AmericaSurgical Oncology Insight · 2025
  23. Surgical cancer patients’ attitudes and beliefs about cannabis at a midwest comprehensive cancer centerSurgical Oncology Insight · 2025
  24. Advancements in the surgical management of pancreatic masses: A comprehensive reviewSurgical Oncology Insight · 2025
  25. Outcomes following diagnostic laparoscopy in patients with peritoneal carcinomatosis deemed ineligible for cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) due to disease burdenSurgical Oncology Insight · 2025
  26. Single versus multiagent chemotherapy for ampullary carcinoma: A propensity matched multivariate analysis of the NCDBSurgical Oncology Insight · 2025
  27. Association of neighborhood socioeconomic status and ethnic diversity with receipt of adjuvant chemotherapy in stage III colon cancer: A population-based cohort studySurgical Oncology Insight · 2025
  28. Collateral vessel formation affects long-term patency of artificial vessels: Insights from 60 cases of superior vena cava reconstruction combined with thymic tumor resectionSurgical Oncology Insight · 2025
  29. Survival in stage IV colorectal cancer at diagnosisSurgical Oncology Insight · 2025
  30. Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort studySurgical Oncology Insight · 2025
  31. Efficacy of Yttrium90 transarterial radioembolization as a bridge to surgery in hepatocellular carcinomaSurgical Oncology Insight · 2025
  32. From genes to glands: The genetic framework of parathyroid syndromesSurgical Oncology Insight · 2025
  33. DOTATATE PET CT tumor volume as a predictor of surgical outcome in patients with metastatic gastroenteropancreatic neuroendocrine tumorsSurgical Oncology Insight · 2025
  34. Liver resection that is less extensive than segmentectomy for hepatocellular carcinoma focused on the fourth branch of the portal veinSurgical Oncology Insight · 2025
  35. Propensity score–weighted analysis of neoadjuvant therapy versus upfront surgical resection in patients with biliary tract cancersSurgical Oncology Insight · 2025
  36. Multidisciplinary management of nonmetastatic locally advanced prostate cancer (T3-4N0M0)Surgical Oncology Insight · 2025
  37. Survival and morbidity following metastasectomy for stage IV melanoma in the era of systemic therapy: A multicenter retrospective cohort studySurgical Oncology Insight · 2025
  38. National disparity in guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosisSurgical Oncology Insight · 2025
  39. Impact of a technology enhanced breast multidisciplinary cancer conferenceSurgical Oncology Insight · 2025
  40. The evolving treatment for early-stage lung cancer: ImmunotherapySurgical Oncology Insight · 2025
  41. Starting a Hepato-Pancreato-Biliary surgery program from scratch: Closing the gap in West AfricaSurgical Oncology Insight · 2025
  42. A single institution experience using ultrasound-guided intralesional immunotherapy in recurrent melanomaSurgical Oncology Insight · 2025
  43. Society of surgical oncology medical student & trainee primer for breast surgical oncologySurgical Oncology Insight · 2025
  44. Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapySurgical Oncology Insight · 2025
  45. Hepatic and peri-hepatic cytoreductive surgery in low-grade appendiceal mucinous neoplasmsSurgical Oncology Insight · 2025
  46. Optimal surveillance for detecting sarcoma lung metastasis – A systematic reviewSurgical Oncology Insight · 2025
  47. Impact of clinicopathologic factors on the number of lymph nodes examined in patients with melanomaSurgical Oncology Insight · 2025
  48. Circulating tumor DNA predicts recurrence in patients receiving adjuvant hepatic artery infusion chemotherapy for resected colorectal liver metastasesSurgical Oncology Insight · 2025
  49. Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinomaSurgical Oncology Insight · 2024
  50. Prognostic impact of the CALLY index in patients with resectable pancreatic cancerSurgical Oncology Insight · 2024